Company / Depreciation & Amortization
Avanos Medical, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$38.9M
FY2025
5-year range
$38.3M / $47.7M
FY2021-FY2025
Trend
-14.5%
vs FY2024
Sector context
#82 of 135
Health Care
What the data says
At $39M, Avanos Medical, Inc.'s depreciation & amortization ranks #54 of 135 in the Health Care sector. Depreciation & Amortization has declined for 3 consecutive years, from $48M in FY2022 to $39M in FY2025.
Based on SEC 10-K filings.
$39M in FY2025 with a 5-year CAGR of -1.9%.
Improved from $46M to $39M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -6.6%
- 5-Year CAGR
- -1.9%
- 10-Year CAGR
- -
Sector benchmark
#54 of 135 in Health CareTop 39% of 135This company $38.9M Sector average $334.5M
▼
-88.4% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s depreciation & amortization has declined for 3 consecutive years.
- 5-year CAGR of -1.9%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 14.5% year-over-year.
- Ranks #82 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.9M | -14.5% |
| FY2024 | $45.5M | -1.3% |
| FY2023 | $46.1M | -3.4% |
| FY2022 | $47.7M | +24.5% |
| FY2021 | $38.3M | -10.7% |
| FY2020 | $42.9M | +16.3% |
| FY2019 | $36.9M | +10.1% |
| FY2018 | $33.5M | -43.7% |
| FY2017 | $59.5M | -8.7% |
| FY2016 | $65.2M | -0.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026